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Abstract: Visceral pain is both different and similar to somatic pain - different in being poorly localized and usually 
referred elsewhere to the body wall, but similar in many of the molecular mechanisms it employs (like TRP channels) and 
the specialization of afferent endings to detect painful stimuli. TRPV1 is sensitive to low pH. pH is lowest in gastric juice, 
which may cause severe pain when exposed to the oesophageal mucosa, and probably works via TRPV1. TRPV1 is found 
in afferent fibres throughout the viscera, and the TRPV1 agonist capsaicin can recapitulate symptoms experienced in 
disease. TRPV1 is also involved in normal mechanosensory function in the gut. Roles for TRPV4 and TRPA1 have also 
been described in visceral afferents, and TRPV4 is highly enriched in them, where it plays a major role in both 
mechanonociception and chemonociception. It may provide a visceral-specific nociceptor target for drug development. 
TRPA1 is also involved in mechano-and chemosensory function, but not as selectively as TRPV4. TRPA1 is colocalized 
with TRPV1 in visceral afferents, where they influence each other’s function. Another modulator of TRPV1 is the 
cool/mint receptor TRPM8, which, when activated can abrogate responses mediated via TRPV1, suggesting that TRPM8 
agonists may provide analgesia via this pathway. In all, the viscera are rich in TRP channel targets on nociceptive 
neurones which we hope will provide opportunities for therapeutic analgesia. 
Keywords: Pain, mechanosensitivity, inflammation. 
INTRODUCTION  
 This review will explore the TRP channel family for pos-
sible targets that could reduce visceral pain in the clinic. 
Chronic pain and discomfort from the viscera affect up to 
10% of the general population, and therefore represent a 
large unmet need for treatment and consequent economic 
impact, but leading off the science behind visceral pain. To 
understand how pain is evoked in the viscera and how pain 
signals are transmitted to the central nervous system, we 
need to know what types of sensory fibres there are and what 
they signal. We must also have an idea about the molecular 
basis of sensory transduction, and how this system changes 
in disease. No systemically active drugs are yet available for 
clinical use that target TRP channels, although some have 
been through clinical trials that hold promise for use in 
treatment of visceral pain. These and other opportunities will 
be identified here. 
 Our group has focussed on the colon as a source of visce-
ral pain, since this is one of the most common reasons for-
clinical consultation. However we expect many of the prin-
ciples that apply in the large intestine will apply elsewhere. 
Instances where there are clear differences between viscera 
are identified specifically. 
 
*Address correspondence to this author at the Wingate Institute, 26 Ashfield 
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What Types of Sensory Fibres are there and what do 
they Signal? 
 Sensory afferent peripheral endings are classified into 5 
functional subtypes in the mouse colon according to the lo-
cation of their mechanoreceptive fields [1, 2]: mucosal, mus-
cular (or tension receptor), muscular-mucosal (or tension-
mucosal), serosal and mesenteric afferents Fig. (1) [1-4]. 
Mucosal afferents respond only to fine tactile stimulation of 
the epithelium., They appear anatomically as bare endings in 
the lamina propria [5]. Muscular afferents (a.k.a. tension 
receptors) respond to distension at physiological levels 
(<20mmHg), and have specialized terminals associated with 
myenteric ganglia [6-8]. Serosal and mesenteric afferents 
respond at painful levels of distension (>40mmHg) [1, 4, 9, 
10] and appear as varicose branching axons apposed to blood 
vessels [11]. Muscular-mucosal afferents respond to both 
touch and distension stimuli, but their anatomy is not known. 
These classifications are based on functional observations, 
and we are still working on matching anatomy and physiol-
ogy. Other classifications have been made in mouse and 
other species, which may be confusing, but there appears to 
be agreement that there are fibres with low thresholds to dis-
tension, those with high thresholds, fibres that are distension-
insensitive (most likely mucosal afferents), and genuinely 
mechanically-insensitive fibres that respond normally only to 
chemical stimuli [12, 13]. It is probably wrong to name 
fibres based on the layer of the gut wall where their receptive 
field appears to be, and better to wait until their structural 
identity is confirmed. For example, high threshold afferents 
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are not only in the serosa and mesentery, but also in the sub-
mucosa [11]. 
 Mucosal afferents are distributed throughout the gut, al-
though they are rarely found in the mid-colon [1]. They are 
unlikely to contribute to direct conscious perception of 
events in the gut, except in the anal sphincter and pharynx, 
where conscious discrimination of solid, liquid and gas are 
required. It follows that in other locations in between they 
may be important in modulating perception of events de-
tected by other afferents such as distension and contraction. 
Also they most likely contribute to subliminal autonomic 
reflexes controlling gut function. Stimulation of gastric and 
small intestinal mucosal afferents is commonly associated 
with satiety after a meal, and in more extreme cases with 
unpleasant sensations associated with nausea and vomiting. 
This follows their potent activation by hormones and media-
tors released from enteroendocrine cells and mucosal mast 
cells [14]. Their functions in the lower bowel are something 
of a mystery. Muscular-mucosal (a.k.a. tension-mucosal) 
receptors are found in the oesophagus and in the rectum. 
These afferents detect both touch and distension, and there-
fore function as both muscular and mucosal afferents. Their 
physiological role is undetermined, but it is possible they 
may play a specialized role in detecting passage of solid or 
semi-solid material. The functional roles of other classes of 
sensory fibres are more straightforward: muscular receptors 
provide perception of distension or contraction; serosal and 
mesenteric afferents detect high amplitude contraction, 
overdistension, and distortion of blood vessels [15, 16]. The 
structure and localization of afferent endings are clearly very 
important in determining their function. However their mo-
lecular machinery in the form of ion channels, receptors and 
enzymes is also critical, and potentially supersedes their ana-
tomical specialisations. 
 Sensory nerves follow 3 main pathways from the gut to 
the CNS - vagal, splanchnic and pelvic nerves. Cell bodies of 
vagal afferent fibres are in the nodose and jugular ganglia; 
splanchnic afferent cell bodies are in the spinal thoracolum-
bar dorsal root ganglia (DRG); and pelvic afferent cell bod-
ies are in the lumbosacral DRG. Abdominal vagal afferents 
are associated with non-nociceptive responses such as satiety 
and nausea, although a subpopulation of oesophageal vagal 
afferents responds at relatively high thresholds to intra-
luminal pressure suggesting a role in pain [17]. All the 
viscera are innervated by spinal pathways, which are associ-
ated with sensations of pain, discomfort, bloating, and ur-
gency to void [15]. Correspondingly, most muscular vagal 
afferents respond over a narrow range of distension pres-
sures, whereas spinal afferents have either a wide dynamic 
range or a narrow range with high thresholds [4, 18, 19]. Not 
all spinal afferents are the same, such that the pelvic pathway 
contains both non-nociceptive and nociceptive afferents, 
whilst splanchnic afferents are almost exclusively nocicep-
tive, with few mucosal and muscular afferents, [1] and are 
therefore useful for studies exclusively of pain. Understand-
ing the specialized roles of TRP channels in visceral pain 
depends on determining which of the afferent subtypes and 
pathways express which TRP channels, and what happens 
when we interfere with their function in each subtype. 
 
Fig. (1). Pathways and subtypes of gastrointestinal afferents, based mainly on our evidence from mouse experiments. The vagal and spinal 
pathways are shown on mirror images of the gut. The locations of endings are based on functional localization of mechanoreceptive fields, 
which in some cases has been confirmed by anatomical studies. The splanchnic and pelvic innervations of the colon overlap in the distal 
colon (not shown), otherwise they are separate. Tension-mucosal and muscular-mucosal afferents are not shown, but have properties 
consistent with a location of endings in both layers of the gut. Adapted from [101]  
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Roles of TRP Channels in Visceral Sensory Signalling 
 As outlined elsewhere in this volume, the TRP family 
comprises 5 sub-families (TRPA, TRPC, TRPM, TRPP, 
TRPV) in mammals, which share several key properties: 
they are non-selective cation channels and most have six 
trans-membrane domains. They were first identified as 
channels mediating brief excitatory events in non-
mammalian sensory systems, although their roles extend 
well beyond this initial association as we shall describe. 
They have been grouped according to structural similarities, 
although we discuss them below in order of the focus on 
visceral sensory pathways. The reader is referred also to 
reviews by Clapham [20], Dhaka et al. [21] and Christensen 
& Corey [22]. TRPs been studied intensively in a number of 
fields, including pain [23], respiratory and cardiac function 
[24, 25], ion metabolism and absorption [26]. 
 TRPV1 is activated by the pungent extract of chillies, 
capsaicin. TRPV1 is more highly expressed in gut 
innervating afferents than skin innervating afferents [27], 
with up to 60% of lumbosacral and 82% of thoracolumbar 
colonic DRG neurones immunoreactive for TRPV1 [13, 27, 
28], which is similar to the proportion of thoracic gastric 
DRG neurones [29]. TRPV1 is found correspondingly in 
peripheral terminals of gut afferents [30], and in 40-80% of 
gastric vagal afferent neurones [29, 31].  
 TRPV4 responds to extracts of the herb Andrographis 
Paniculata [32, 33], and cooresponds to the mammalian 
homologue of the C-elegans osmosensory gene Osm-9 [32]. 
TRPV4 has been localized at sites of mechanotransduction 
including inner-ear hair cells, sensory neurones, and endings 
[32]. TRPV4 is enriched in sub-populations of DRG sensory 
neurones. There is twenty times more TRPV4 mRNA in 
retrogradely labelled colonic sensory neurones than in the 
rest of the DRG within the thoracolumbar (splanchnic) DRG. 
and 3-8 times the levels of TRPV4 in retrogradely labelled 
gastric vagal sensory neurones. TRPV4 is expressed in 38% 
of gastro-oesophageal vagal afferents, 65-76% of splanchnic 
colonic DRG neurones and 58% of pelvic colorectal DRG 
neurones [3]. In the periphery TRPV4 protein is found to co-
localize with CGRP in serosal and mesenteric colonic nerve 
fibres, but it is scarce in intramuscular or mucosal endings. 
This distribution is seen in both mouse and human tissue [3]; 
it correlates well with the functional role of TRPV4 (see 
below). Other vanilloid TRP channels include TRPV2,3,5 
and 6, whose function in the gut remains to be investigated. 
TRPV2, but not TRPV3 is expressed in gastric vagal afferent 
neurones [34]. 
 TRPA1 responds to a range of environmental irritants 
[35-37] and extracts of herbes and spices, including mustard, 
cinnamon, garlic, and oregano [38-41] (Table 1). TRPA1 is 
localized in 55% of gastric vagal afferents, 54% of 
splanchnic colonic afferents and 58% of pelvic colonic 
afferents [42].  
 TRPM8 responds to menthol, icilin and eucalyptol, and 
probably mediates a cooling and soothing sensation [21, 43]. 
Therefore TRPM8 may be important in alleviating pain. 
TRPM8 is localized in DRG neurones that do not co-localize 
with the “algesic” TRPs V1 and A1 [44]. It will be important 
to know about TRPM8 expression and function in specific 
subpopulations of visceral afferents, which, like in skin, may 
have an anti-nociceptive function. The TRPC family has 6 
members, most of which operate as classical calcium 
channels, rather than sensory channels. Their sensory role in 
the gut has not yet been published.  
 Other TRP channels shown to have potential sensory 
roles elsewhere, including TRPC and TRPP channels have 
not been investigated in visceral sensation and will not be 
considered further here. 
The Molecular Basis of Visceral Sensory Transduction  
 TRPs are primary transducers of thermal, mechanical and 
chemical stimuli. Thermal transduction is unlikely to be 
important in the viscera apart from in sensitized sensory 
neurons (see later) and so will not be discussed in detail here. 
There are several mechano- and chemo-sensory properties 
(outlined below) that suggest TRPs are important targets in 
visceral sensory pathways. Despite their established roles as 
chemosensors, there is little conclusive evidence that TRPs 
function as mechanosensors. This has been elusive because it 
demands mechanosensory function studies in isolated 
channels, intact sensory fibres and in intact animals.  
 TRPV1 is activated by a range of herb and spice extracts 
including capsaicin; also by noxious heat and low pH. This 
produces the characteristic burning feeling evoked by chillies 
in the mouth. When administered intracolonically capsaicin 
causes pronounced pain [45]. However capsaicin also 
activates non-nociceptive upper gastrointestinal vagal 
afferents [46],.. TRPV1 knockout mice have no significant 
deficit in mechanosensory function of somatic nociceptors 
[47], but they have deficits in TRPV1-/- visceral 
mechanoreceptors (Table 2). TRPV1 knockouts had reduced 
vagal afferent responses to distension of the stomach and 
oesophagus [48]. They also have reduced responses to 
distension of jejunal wide-dynamic range afferents, but they 
had normal function of low threshold and high threshold 
afferent populations [49]. TRPV1 deletion significantly 
reduced the distension responses of pelvic muscular and 
muscular/mucosal afferents of the distal colon/rectum [50], 
but did not affect responses to mucosal stroking. We don’t 
know about effects on serosal afferents. Therefore, TRPV1 
contributes to the mechanosensitivity of distension sensitive 
gastro-oesophageal, jejunal and pelvic colonic afferents. 
Similar roles were suggested in bladder afferents [51]. 
Capsaicin potently activates splanchnic and pelvic colonic 
serosal afferents, which is followed by pronounced 
mechanical desensitization exclusively in splanchnic 
afferents [13]. This suggests that the coupling of TRPV1 
may differ between splanchnic and pelvic pathways. Since 
TRPV1 -/- mice had normal somatic mechanical pain 
sensitivity [47], and their behavioural responses to colorectal 
distension were reduced [50], it follows that TRPV1 is 
important in the signalling of mechanical stimuli specifically 
from the viscera.  
 Because TRPV1 responds to low pH [52], this places it 
as a prime candidate for detecting refluxed acid in the 
oesophagus, and thus giving rise to sensations like heartburn. 
Indeed it has been localized to fibres in the human 
esophageal mucosa [53, 54]. TRPV1 knockout mice develop 
significantly less inflammation after esophageal acid 
exposure compared with wild-types [55], suggesting a role 
perhaps in neurogenic inflammation. In the guinea-pig, 
TRP Channels in Visceral Pain The Open Pain Journal, 2013, Volume 6    26 
‘nociceptive-like’ esophageal tension sensitive vagal 
afferents are distinguishable from ‘non -nociceptive-like’ 
afferents because they respond to capsaicin [17]. 
‘Nociceptive-like’ tension receptors in the esophagus are 
stimulated by acid [56]. However, responses of ‘non-
nociceptive’ tension receptors to acid are less well-defined. 
Rong et al. [49] showed that responses of jejunal afferents to 
acid were reduced by up to 50% in TRPV1 knockouts, 
indicating TRPV1 has a major, but not exclusive role in 
detecting low pH. 
 TRPV4 is implicated in mechanotransduction, since 
TRPV4 knockout mice have reduced behavioural responses 
to painful mechanical stimuli to the skin [32, 57]. However, 
deletion of TRPV4 has no effect on vagal afferent function 
[3], which correlates with low levels of TRPV4 expression in 
gastric vagal afferents. In contrast, in colonic afferents 
TRPV4 is enriched, and mechanosensory responses are 
greatly reduced in TRPV4 knockouts, and mechanosensory 
thresholds are increased. This is the case for both splanchnic 
and pelvic high threshold (serosal and mesenteric) afferents, 
consistent with TRPV4 expression in their peripheral 
endings The excitability of afferent endings, their electrical 
thresholds and conduction velocities were identical in wild 
type and knockout mice, indicating TRPV4 has a specific 
role. However, as was the case in the vagal pathway in this 
study, pelvic mucosal and muscular afferents were normal. 
Therefore, we concluded that TRPV4 makes a highly 
specific contribution to mechanosensory function of colonic 
high threshold afferents; as such it is the only nociceptor-
specific TRP channel so far identified. 
 Afferent responses to mechanical stimuli can be 
augmented by pharmacological agents that induce opening 
of the TRPV4 channel. The endogenous arachidonic acid 
metabolite 5,6-EET is a TRPV4agonist,, which causes 
potentiation of mechanosensory responses in wild-type mice, 
but not in TRPV4 knockouts. Ruthenium red, a non-selective 
TRP channel blocker, correspondingly reduces 
mechanosensitivity only in wild-type mice [3, 58]. In 
isolated colonic DRG neurones 4?-PDD, a synthetic TRPV4 
agonist, caused significant TRPV4-mediated calcium influx 
[59], which is consistent with effects of TRPV4 activation in 
colonic afferent endings. Therefore it is clear that alterations 
in the pharmacology of splanchnic and pelvic colonic 
afferents parallel the changes in mechanosensitivity in 
TRPV4 knockouts, indicating there may be potential for 
development of a nociceptor-specific analgesic.  
 The selective role of TRPV4 in high-threshold afferents 
translates to a role in pain perception in vivo,. Visceromotor 
responses to noxious colorectal distension were decreased in 
TRPV4 knockouts or in mice with down-regulated TRPV4 
expression (via intervertebral siRNA delivery) [3, 59]. This 
was apparent only at higher distension pressures. 
Intracolonic administration of 4?-PDD in wild-type mice 
caused activation of second-order neurones in the 
lumbosacral spinal cord and caused visceral hypersensitivity 
to colorectal distension [59].  
 TRPA1 knockout mice have reduced mechanosensitivity 
of colonic splanchnic and pelvic serosal and mesenteric 
afferents, and responses of vagal and pelvic mucosal 
afferents to mucosal stroking, In contrast, the distension 
responses of vagal tension receptors and pelvic muscular and 
muscular/mucosal afferents are similar to wild-types [42]. 
Therefore TRPA1 contributes to mechanosensation in both 
tactile and nociceptive afferents, but not in others. 
Correspondingly a TRPA1 antagonist reduces 
mechanosensory responses of sensory neurites of DRG 
neurons [60]. In conscious rats, TRPA1 antisense 
oligodeoxynucleotide intrathecally reduced colitis-induced 
hypersensitivity to colonic distension and mustard oil [61]. 
Although TRPA1 may not be specific to one afferent 
population like TRPV4, it is clearly evident as a target for 
reducing signaling of pain from the colon. When its role in 
mucosal afferents becomes clearer, this may provide 
important knowledge about the functional role of the 
channel, and the role of mucosal afferents in visceral 
sensation.  
 TRPM8 agonists are already known to activate non-
nociceptive vagal afferent neurones innervating the gut [34]. 
Our recent study provided anatomical and molecular 
evidence for the expression of TRPM8 in a sub-population 
of colonic afferent neurons, and showed direct activation of 
high-threshold colonic afferent fibres through TRPM8 and 
an interaction of TRPM8 with both TRPV1 and TRPA1, 
which alters the properties of mechanoreceptive colonic 
afferent endings [62]. Our major findings were that pro-and 
anti-nociceptive roles may exist for TRPM8 in high-
threshold colonic afferents, since it produces initial 
activation followed by mechanical desensitisation. TRPM8 
activation also influences TRPV1 and TRPA1 sensitivity, 
resulting in diminished agonist-evoked responses.  
TRPs in Effector Systems 
 TRPs can also function as effector channels, providing a 
means of excitation of cells in response to activation of G-
protein coupled receptors and other types of channel. This is 
an important function of most TRP sub-families, and in some 
cases it is their only identified role, for example in some 
members of the TRPC family [63]. The effector function of 
TRPs is important in sensory nerve function, such as 
inflammatory pain evoked by the mediators bradykinin [35] 
and mast cell proteases [64]. TRPV1 is not thought to be 
directly mechanically gated; therefore its apparent role in 
mechanosensation may be attributable to indirect effects on 
neurone excitability or via interactions with other receptors 
or TRP channels. For example, 5-HT enhances sensitivity to 
heat in colonic DRG neurones via TRPV1 (Sugiura et al., 
2004), so that they are activated at normal body temperature. 
Cannabinoids modulate TRPV1 either directly by a direct 
interaction with the eicosanoid mediator anandamide with 
the channel itself, or by coupling through intracellular 
pathways after acting on G-protein coupled cannabinoid 
receptors [65-67]. The protease receptor PAR2 sensitizes 
TRPV1 through specific intracellular pathways [65]. 
 In addition to PAR2 coupling with TRPV1, there is also 
evidence for interaction with TRPV4, which may contribute 
to visceral hypersensitivity [58, 59]. TRPV4 and PAR2 are 
often co-expressed in colonic sensory neurones [58, 59]. In 
isolated colonic DRG neurones PAR2- activating peptide 
(AP), sensitizes TRPV4-induced currents, whilst PAR2-AP 
also directly activates splanchnic serosal colonic afferent 
endings in wild-types, but not in TRPV4 knockouts [58]. 
Intra-colonic administration of PAR2-AP increases the 
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behavioural response to noxious colorectal distension, an 
effect also lost in TRPV4 -/- mice [58, 59].  
 There is evidence that PAR2 interacts with TRPA1 via 
similar intracellular mechanisms to those involved with 
TRPV1 [68]. TRPA1 can also be indirectly activated via 
bradykinin B2 receptors [35, 69], which mediates 
bradykinin-induced mechanical hypersensitivity in guinea-
pig oesophageal afferents [70]. In the colon bradykini 
selectively induces mechanical hypersensitivity of 
splanchnic serosal afferents but not pelvic afferents [12], an 
effect that is lost in TRPA1 knockouts [42].  
 Other TRPs are also associated with effects of 
bradykinin, including TRPC1, whereby activation via the B2 
receptor opens TRPC1 [71]. It appears that TRPC1, TRPV4 
and TRPA1 all interact with inflammatory G-protein coupled 
receptors. In contrast to these channels, TRPM8 function is 
inhibited by BK via a reduction in intracellular 
phosphoinositide (PIP2) levels [21, 72].  
 In addition to these roles in neurones, TRPA1 is also 
involved in mediator release from enteroendocrine cells. 
Enterochromaffin cells express TRPA1 and release serotonin 
in response to the TRPA1 agonist AITCl [73], which also 
releases CCK from other enteroendocrine (STC-1) cells [74]. 
These data suggest that dietary spices may augment release 
of mucosal mediators in response to nutrients.  
 There appears to be great redundancy amongst TRP 
channels. Although they function as effectors for many 
pathways, single TRP knockouts normally retain some 
response to the initial stimulus, for example in bradykinin-
evoked excitation of airway afferents [75], suggesting there 
are parallel mechanisms – either other TRPs or completely 
distinct pathways. 
 TRPs may interact with one another, such as TRPA1 and 
TRPV1, which are co-localized in nociceptive DRG neurons. 
Thus, TRPA1 activation causes cross-desensitization of 
responses to capsaicin and vice versa [76]. Whether or not 
TRP channels may couple together positively, and therefore 
act as effectors for one another, is yet to be determined. 
Changes in Sensory Signalling in Disease 
 Studying the effects of inflammation on visceral afferent 
endings is important not only to determine mechanisms of 
inflammatory pain, but also to find a model for chronic 
visceral pain in humans (eg. [77]). Most published 
electrophysiological studies have focused on the 
mechanosensory responses of afferents, in particular to 
colorectal distension, and how this response is altered by 
inflammation. For example, a recent study [78] showed that 
acute colitis in rats induced by TNBS resulted in increased 
responses of pelvic afferent C-fibers to colorectal distension 
in vivo. This increased sensitivity was reduced by a TRPV1 
antagonist. On the other hand, an earlier study by Sengupta 
et al. [79] using an identical in vivo protocol, recording from 
the same population of afferents did not reveal any 
sensitization, so there is clearly controversy in this area. 
Similar to Sengupta’s [79] findings in rat, Jones et al. [80] in 
a mouse zymosan colonic inflammation model saw no 
change in mechanosensitivity of pelvic muscular or 
muscular-mucosal afferents. The behavioural response to 
colorectal distension was, however, increased after zymosan, 
and this persisted in TRPV1 knockouts, so the mechanism 
underlying pain hypersensitivity was not revealed. In a 
model of colonic hypersensitivity induced by neonatal 
colonic irritation in rats [81], TRPV1 inhibitors were 
effective in reducing pain responses to colorectal distension. 
Increased expression of TRPV1 in DRG is evident in this 
model, as well as in a TNBS colitis model [82], suggesting 
that TRPV1 up-regulation may be a mechanism by which the 
effect of a TRPV1 antagonist becomes manifest. This 
mechanism was also evident In a model of pancreatic 
inflammation [83]. The up-regulation of function via TRPV1 
can be long-term, and may lead to cascades of events 
resulting in hypersensitivity [81, 82]. Alternatively, the 
translocation of TRPV1 to the cell membrane may have an 
important influence on its function without changes in 
mRNA expression [84]. Studies of biopsies from patients 
with visceral hypersensitivity, either in IBS [85] or in non-
erosive reflux disease [54], show that there may be more 
than three times the mucosal fibres containing TRPV1 
compared to asymptomatic controls, and that expression 
correlates with symptoms. Furthermore, Chan et al. [86] 
showed that increased rectal sensitivity was associated with 
increased TRPV1 fibres throughout the gut wall. 
 Mustard oil, a selective TRPA1 agonist, has long been 
used as a visceral inflammatory model to sensitize 
nociceptors and provoke tissue damage [45]. Therefore 
TRPA1 has a role not only in activation of sensory 
pathways, but also in local neurogenic inflammation, 
presumably by evoking release of peptides like substance P 
from peripheral endings. Studies from our laboratory are 
nearing completion to determine if TRPA1 function and/or 
expression are increased in chronic visceral pain in animal 
models or IBS patients. 
 A combination of peppermint oil (a TRPM8 agonist) and 
caraway oil attenuates post-inflammatory visceral 
hyperalgesia in rats [87], which may correlate with its 
therapeutic effects in patients described below. TRPM8 
activation can interfere with transduction via TRPV1 and 
TRPA1 [62], which is a possible mechanism for this effect. 
Therapeutic Opportunities 
 Allodynia and hyperalgesia to mechanical events like 
distension and contraction are hallmarks of chronic visceral 
pains [88-90], along with inflammation, which may be very 
low-grade histologically [91-93]. Therefore, it is clear that 
therapies are needed that reduce signalling of nociceptive 
mechanosensory and inflammatory events. From the discus-
sion above TRPs are closely involved in both of these pro-
cesses. Normally, there is a constant stream of unperceived 
signals from the gut, which is involved in autonomic reflexes 
controlling physiological gut function. We must therefore 
avoid interfrerence with this information and focus on no-
ciceptive signals in targeting visceral pain to avoid altering 
normal function. So far, TRPV4 is the only TRP channel that 
appears to be nociceptor-specific, but ironically is the least 
well-served pharmacologically. As with many other TRPs, 
its localization is not, however, confined to sensory neurones 
[94], so the potential exists for off-target adverse effects. 
Such effects have hampered the progress of other types of 
treatments for visceral pain, but it could be argued that in the 
case of TRPs, there are fewer other target tissues to be con-
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cerned about. We hope this chapter may rencourage further 
development of selective drugs, either as pharmacological 
treatments, or tools to investigate the roles of TRPs more 
effectively. Another interesting application of TRP pharma-
cology is in diagnostic testing for functional gastrointestinal 
disorders. Administration of capsaicin produces more symp-
toms including pain, warmth and pressure in functional dys-
pepsia patients compared with controls [95]. Although the 
predictive value is far from ideal at around 50%, there is 
promise for development of better provocative tests for func-
tional disorders, considering we have very few options cur-
rently. 
 Herbal preparations containing peppermint have been 
successful in the treatment of functional dyspepsia [96], 
although whether this is a sensory or motor effect and 
whether it is mediated via TRPM8 remain to be seen. Sev-
eral clinical trials have been conducted with selective TRP 
antagonists for pain [97], such as the TRPV1 antagonist, 
AMG-517, which was discontinued due to hyperthermia 
after systemic administration. Pharmaceutical companies are 
currently determining whether this liability for TRPV1 an-
tagonists can be managed. Site-specific administration of 
TRPV1 desensitization or targeting non-thermosensitive 
regions of the TRPV1 molecule would circumvent this issue, 
and such approaches have shown promise in other visceral 
neurological disease, reviewed elsewhere [98, 99]. Whether 
or not the gut is an appropriate place for site-specific inter-
ventions remains a difficult question. Within the TRP family, 
by far the greatest attention has been given to TRPV1 as a 
therapeutic target, and there is still potential for its successful 
exploitation despite the current problems, not only in visce-
ral pain, but also in neurogenic inflammation [100]. Hope-
fully there are also many other candidates within the TRP 
family. We discussed earlier evidence that the role of TRP 
channels may be increased in pathological conditions such as 
IBS; this suggests that normalizing their function may be 
sufficient for therapeutic benefit without blocking their func-
tion totally, and may provide more scope for entry of com-
pounds into the market. It is also possible that the role of 
TRPs as effectors for other receptors associated with pain 
may provide a bonus in the antinociceptive actions of anti-
TRP therapy. 
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